omniture
LUNIT INC

Latest News

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to t...

2024-03-18 21:00 1012

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy...

2024-03-14 21:00 1432

Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured

- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for...

2024-03-13 21:00 1159

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting ...

2024-02-28 22:03 957

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

 - A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-po...

2024-02-16 22:03 2140

Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

- Lunit's AI-powered chest X-ray analysis solution shows highest AUC of 0.93 in a recent multi-cent...

2024-01-17 22:15 1301

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

* Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abn...

2024-01-16 22:04 1571

Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

- Lunit's strategic global leap: to acquire all of Volpara shares at AUD 1.15 per share, envisionin...

2023-12-14 22:05 1268

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's Bre...

2023-12-11 22:30 1406

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

* Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through...

2023-11-30 22:10 1548

AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology

* AI-powered spatial analysis of tumor-infiltrating lymphocytes using Lunit SCOPE IO provides acc...

2023-11-27 22:05 1083

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accura...

2023-11-22 22:07 1644

Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

-    Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detectio...

2023-11-16 22:00 1296

Lunit Secures $150 Million in Capital Increase

* Fund fully paid-in as of November 9, achieving over 100% shareholder participation SEOUL, South...

2023-11-15 22:00 1586

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

- Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market ...

2023-11-14 22:00 1323

Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

- Lunit INSIGHT suite, Lunit's AI-driven solutions for early detection of cancer, featured in Cance...

2023-11-13 22:00 1113

Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

* Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for c...

2023-11-06 21:00 1192

AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023

* Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment ar...

2023-11-01 21:08 1471

Lunit Joins as an Associate Partner with the World Economic Forum

- Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and ...

2023-10-31 21:00 1298

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

-       Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembroliz...

2023-10-27 21:07 2868
12345